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ABSTRACT - Forty-six lithium (Li) patients who had been on Li for about 1-11 
years were studied while on Li and after about 3 months (7 weeks-26 months) off Li. 
Kidney function was compared between patients on Li and the same patients off Li, 
and, in 32 matched pairs, between patients on and off Li and psychiatric controls. 
Urine osmolality (U-osmol) was significantly lower, urine volume higher in patients 
on Li than in controls. Measures of both glomerular and tubular function improved 
when Li-patients discontinued medication. U-osmol remained somewhat lower than 
in controls and was negatively correlated with time-on-Li. Although serum creatinine 
was somewhat higher in Li-patients off Li than in controls, clearance values were not 
different between the two groups. Long-term lithium treatment causes a permanent 
reduction of tubular function. Time-on-Li is a risk factor. In this population the 
reduction was clinically insignificant. In addition, Li treatment causes a reversible 
reduction of both tubular and glomerular function. The results can probably be 
generalized to other outpatient Li populations with the same time-on-Li and with 
U-osmol below 800 mOsm/kg during ongoing treatment. 
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This is the third paper reporting on a study of 
lithium (Li) treated patients, triggered by alarm- 
ing reports in 1977 by Hestbech (1) and Hansen 
(2), indicating that long-term Li-treatment might 
cause irreversible renal damage. The first two 
papers gave a cross-sectional view of patients 
treated at the Sahlgrenska Hospital in Gothen- 
burg, Sweden (3) and critically surveyed a num- 
ber of studies pertinent to  the subject matter (4). 
The present paper gives data on a selected group 
of patients from the Sahlgrenska Hospital (hos- 
pital 1) and from the Rilambshov Hospital in 
Stockholm, Sweden (hospital 2). 
The aim of the present paper is to  answer the 
following questions: 
1 .  Does long-term Li treatment in nontoxic 
doses cause a permanent disturbance of tubular 
or glomerular function? 
2. Is there a relationship between such a 
disturbance and treatment variables? 
Design 
The investigation started in March, 1978, at the 
Sahlgrenska Hospital and was continued in 1979 
at the Rilambshov Hospital where it was closed 
in May, 1982. All patients except one were 
outpatients, 124 at  Sahlgrenska, 38 at Rilambs- 
hov. The former group has been previously 
described in detail (1). 
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Table I 
The total Li population and the matched group. Demographic and clinical characteristics 
Matched group 
Li-patients Controls 
Original group Withdrawal group 
n 162 46 32 
Sex M/F% 36/64 35/65 3 1 /69 
Age (years) 49f15 49f 15 495 16 49+ I6 








(n  = 159) 
*Average S-Li (mEq/l) 
*Number of patients with 
max S-Li > 1.5 mEq/l 
31 33 38 44 
51 48 47 38 
12 4 6 9 
3 4 6 6 
3 11 3 3 
68f37 61+35 68f33 
(2-160) (8-136) (25-136) 
0.77f0.11 0.75+0.11 0.74f0.09 
(0.6-1 . I )  (0.6-1.1) (0.6-0.9) 
9 3 1 
*Range > 1.5 mEq/l 1.6-3.4 1.7-3.4 2.0 
* Only hospital 1. 
UP = unipolar affective disorder; BP = bipolar affective disorder; CP = cycloid psychosis; SCH = schizophrenia; US = 
unspecified affective disorder. 
Of the total of 162 patients 40 were selected 
for Li withdrawal according to  the following 
criteria: 1) reduced kidney function, defined as 
urinary osmolality (U-osmol) below 800 mOsm/ 
kg H,O in a desamine-8-D-arginin vasopressin 
(DDAVP) test (3) or glomerular filtration rate 
(GFR) below -2 SD for age as measured by the 
T r - E D T A  (ethylenediaminetetra-acetic acid) 
clearance method ( 5 ,  6); 2) no psychiatric con- 
traindication for withdrawal; 3) patient consents 
to withdrawal. We studied renal function imme- 
diately before Li withdrawal (on Li), and at the 
end of a Li withdrawal period which should be 3 
months (off Li). During that period the patients 
were treated by their usual doctor with medica- 
tion according to  clinical needs. In addition, six 
patients requested that, in spite of normal renal 
findings, Li should be discontinued. They were 
also included in the study. 
Matching. Controls were not necessarily candi- 
dates for Li treatment but matched with a 
suitable Li-patient according to the following 
criteria: age & 7 years; sex; hospital; diagnosis, 
where unipolar affective disorder (UP), bipolar 
affective disorder (BP), and cycloid psychosis 
(CP) were combined as one “affective” diag- 
nosis, while schizophrenia (SCH) and unspecified 
affective disorder (US) remained separate. Exclu- 
sion criterion was a history of Li treatment of 
any duration. Thirty-two patients who had been 
on Li for more than 2 years were included in the 
matching procedure with control subjects. Table 
1 gives characteristics of the original group, the 
withdrawal group, and the matched group. 
Time-off-Li. Five of the 46 withdrawal patients 
had their Li-free period shortened to less than 3 
months. One relapsed and resumed Li after 7 
weeks, and in four, the time interval between on 
and off Li was 10-12 weeks. Among the remain- 
ing 41, 24 had a time interval of 3-4 months, 
eight had 4-6 months and nine had 7-26 monhts. 
One patient who discontinued Li before entering 
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Table 2 




S-Cre Cre clearance S'Cr-EDTA U-osmol vu Weight 
umol/l rnl/min/l.73 rn* mOsm/kg H,O 1/24 h kg 





Mean diff. f SD 
t 
P 
Number of patients 























19 45 42 38 
79.7 674.3 2.5 70 
(41 - 106) (301-1,013) (1.2-6.3) 
88.2 750.8 1.9 68 
(43- 140) (2 10-1,116) (1.7-6.3) 
-8.5516.5 -76.5+ 134.8 0 . 6 f 0 . 9  2 
2.22 3.81 4.31 3.57 







Cre = creatinine; U-osmol = urinary osmolality; Vu = volume of urine. 
the study, participated only in the matched 
comparison. 
The withdrawal group and the matched group 
are representative of the original population on 
several variables that may be, or are known to 
be, related to  renal function. The only Li-patient 
in the matched group who had a maximum S-Li 
above 1.5 mEq/l showed at that time no clinical 
signs of toxicity. Results from the comparison 
between the Li-patients and controls can, there- 
fore, be generalized to  those of the original 




Diagnostic criteria have been given previously 
Somatic disease. One of the 46 patients admitted 
to insignificant phenacetin consumption. Twen- 
ty-two had a history of clinically significant, 
physical disease. Ten of them had had lower 
tract urinary infection, four of these, in addition, 
cardiosclerosis. One patient had cardiosclerosis 
and a silent urinary tract infection at the exam- 
ination off Li. One had a history of kidney 
stones on two occasions, 5 and 15 years ago; 
intravenous pyelogram performed 1 year before 
participation in this study was normal. One had 
a kidney stone half a year before she entered the 
study, and a history of recurrent cystitis. One 
had a history of what she believed had been an 
attack of acute glomerulonephritis 15 years 
before. One had an attack of pyelitis 1 month 
before she entered the study, and one had an 
attack between the first and second kidney 
function examination. One of them had a signifi- 
cant bacteriuria at the second examination with 
no clinical signs of renal infection. Another 
patient with no history of cardiovascular or renal 
disease had bacteriuria and hematuria at the time 
of the second kidney function tests. She had no 
symptoms of renal infection, and erythrocyte 
sedimentation rates were normal. Two had a 
diagnosis of hypertension (presently with normal 
blood pressure on a diuretic), one of them had 
also hyperlipemia and Parkinson's disease. One 
had a diagnosis of diabetes mellitus (treated 
perorally), and one had a neurological disorder, 
probably multiple sclerosis. Data on cardiovascu- 
lar disease were missing in two patients. 
32 
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Table 3 
Comparison of renal function tests between patients on Li and matched controls 
S-Cre Cre clearance 50 -EDTA U - o s m o 1 vu 
vmol/l ml/min/1.73 m2 mOsm/kg HzO 1/24 h 
(n) (29) (19  (12) (27) (19) 
Mean on Li 84 90 78 662 2.8 
Mean control 82 94 86 798 1.9 
Diff. f SD 2f18 -4f37 -8C26 -136C212 0.9f1.9 
t 0.47 0.39 1.04 3.34 1.93 
P NS NS NS * **  
Number of subjects 
beyond reference range 
Li-patients 1 5 5 23 7 
Controls 0 6 1 13 3 
Abbreviations as in Table 2. 
Table 4 
Comparison of renal function tests between patients off Li and matched controls 
~ ~~ 
S-Cre Cre clearance 5 1 Cr-EDTA U - o s m o 1 vu 
pmol/l ml/min/l.73 m2 mOsm/kg H 2 0  1/24 h 
(n) 
Mean off Li 
Mean control 
Diff. & SD 
t 
P 
Number of subjects 





































Abbreviations as in Table 2 
Thyroid funciion in Li-patients and controls. 
Five patients were on thyroid substitution when 
they entered the study. One of these had been 
strumectomized 25 years before, and another one 
had a slightly elevated level of thyroid stimulat- 
ing hormone (TSH). Three unsubstituted patients 
had high levels of TSH and three had slightly 
elevated levels. 
We did not routinely do thyroid function tests 
in the controls but 35 of 36 examined controls 
had a normal TSH. In one, TSH was increased 
to 23 IU (normal is < 15) and thyroxin level 
decreased. None of the controls had clinical signs 
of thyroid dysfunction. 
Maximal 12 h serum Li (S-Li). Nine patients from 
hospital 1 had had at least one episode of S-Li > 
1.5 mEq/l. S-Li from hospital 2 was not included 
in the analysis because of irregularities in the 
adherence to the 12 h rule. The policy since may 
years, however, of the 
most of the Li-patients, 
low as possible without 
physician in charge of 
was to keep Li dose as 
relapse. 
Controls 
Data from 32 controls were used in the matched 
comparison with Li-patients. Twenty-three con- 
trols, the majority being inpatients, came from 
hospital 1, and nine, the majority being outpa- 
tients, from hospital 2 (Table 1). Diagnostic 
criteria were the same as for the patients. 
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Table 5 
Simple correlations for Li-patients on and off Li and controls 
Renal function parameter 
Lithium patients Con t r o I s Average S-Li 
(hospital 1 )  Age Time-on-Li Age 
*S-Cre 1 0.18 (NS) -0.04 (NS) 0.18 (NS) 
n 33 43 44 
*S-Cre I1 
n 
Cre clear. I 
n 
-Cre clear. I1 
n 
SlCr-EDTA clear. I 
n 






vu  I 
n 
vu  I1 
n 
0.10 (NS) 0.02 (NS) -0.04 (NS) 0.15 (NS) 
32 42 43 57 
-0.15 (NS) -0.14 (NS) -0.23 (NS) 
32 44 45 
-0.25 (NS) -0.10 (NS) -0.43 (**) -0.20 (NS) 
32 42 43 27 
-0.11 (NS) -0.27 (NS) -0.45 (**) 
16 18 19 
-0.13 (NS) -0.25 (NS) -0.57 (***) -0.67 (***) 
29 41 42 47 
-0.20 (NS) -0.39 (**) -0.41 (**) 
33 44 45 
-0.13 (NS) -0.57 (***) -0.34 (*) 
32 45 46 
-0.26 (NS) 0.31 (*) -0.10 (NS) 
33 44 45 
-0.41 (**) 
47 
0.20 (NS) 0.27 (NS) -0.7 (NS) 0.03 (NS) 
32 42 43 33 
* I = on Li. 
I1 = off Li. 
Abbreviations as in Table 2. 
Clinical and laboratory methods 
All patients and controls were examined by me 
or some other experienced psychiatrist. We 
examined them according to a protocol, 
described in detail elsewhere (3). Some.of them 
refused one or other of the kidney function 
tests. Only after a while did we include slCr- 
EDTA clearance in all patients on Li scheduled 
for Li withdrawal. Vr-EDTA clearance values 
from before the change were excluded from the 
statistical analysis to avoid selecting a subgroup 
of patients with low GFR. In contrast, all 
patients off Li were routinely scheduled for W r -  
EDTA clearance. Consequently, all those values 
were included in the statistical analysis, when 
possible. In patients from hospital 2 the 
DDAVP-test and Wr-EDTA clearance were 
done on the same day, and calcium was excluded 
among electrolytes. With a few exceptions, body 
position during "Cr-EDTA clearance was always 
the same - lying or sitting - on and off Li and 
between Li-patients and matched controls. 
Statistics. (In many cases - because of un- 
systematically missing data - n for a given 
statistic is smaller than the actual number of 
patients or controls.) 
Paired t-test comparing 5 measures of renal 
function on and off Li in the same patients (n 
= 45); one-tailed, under the assumption of 
reduced function on Li. The following were 
measures of renal function: serum creatinine 
(S-Cre), 24 h endogenous creatinine clearance 
(Ccre), "Cr-EDTA clearance, U-osmol, and 
24 h urine volume (Vu). 
Paired t-test, comparing the 5 measures of 
32' 
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Table 6 
Correlation between time-off-Li and relative change in renal 
function 
Diff ratio Diff ratio 
n r 
S-Cre 44 -0.11 -0.06 
Cre clearance 42 -0.09 -0.12 
51Cr-EDTA clearance 19 -0.05 -0.06 
U-osmol 44 0.38' 0.36" 
vu  42 -0.06 0.00 
* P < 0.05. 
Abbreviations as in Table 2. 
renal function in patients on Li and matched 
controls (n = 31), and, between patients off 
Li and matched controls (n = 32); one-tailed, 
under the assumption of reduced function in 
Li-patients. 
3) a. Correlation coefficients in Li-patients o n  Li 
(n = 4 9 ,  and off Li (n = 46), and in controls (n 
= 59). Independent variables were average- 
S-Li-during-time-on-Li (average s-Li), time- 
on-Li, and age. Dependent variables were the 5 
measures of renal function on and off Li. 
b. Correlation coefficients in Li-patients (n 
= 45). Independent variable was time-off-Li, 
dependent was change in renal function, calcu- 
lated as 1) the ratio between values off and on 
Li (ratio S-Cre, etc.), and 2) the difference 
between those values (diff S-Cre, etc.) For diff 
U-osmol and ratio U-osmol, time-on-Li was 
also used as independent variable. 
c. Multiple regression analyses in Li-pa- 
tients (n = 45). Independent variables were 
time-off-Li and time-on-Li, dependent were 
diff and ratio U-osmol one at a time. 
4) a. Multiple regression analysis, in patients off 
Li (n = 29), using sex, age, diagnosis, time- 
on-Li and average s-Li as independent varia- 
bles and renal function parameters as depen- 
dent variables one at  a time. To increase 
homogeneity, patients with a diagnosis of 
CP,  SCH and US were excluded from this 
and the following analyses. At step one, sex, 
age, and diagnosis were entered. At step two, 
time-on-Li and average S-Li were added. 
b. Multiple regression analysis in patients 
off Li (n = 37), identical to  4a with the 
exclusion of average S-Li which was missing 
in patients from hospital 2. 
5 )  Multiple regression analysis in matched 
groups off Li (n = 32), using age and time- 
on-Li as independent variables and the dif- 
ference in renal function between Li-patient 
and control, each parameter one at a time, as 
dependent variable. 
6 )  In order to test the appropriateness of the 
straight line model and the possibility of an 
interaction between age and time-on-Li we did 
the following tests, using U-osmol in patients 
off Li as dependent variable (n = 37): 
a. A residual analysis, plotting residuals 
against time-on-Li (test for deviance from the 
straight line model). 
b. Two multiple regression analyses with 
sex, age, diagnosis, and time-on-Li (the latter 
unsquared in the first analysis, squared in the 




r = -0.57*** 
y-940-3.2): 
50 100 I50 
TIME-ON-LITHIUM (months) 
Fig. 1. Correlation between maximum urine 





y = 6 . 3 ~ -  27.5 1 ;;;, -200 
20 4 0  6 0  80 
TIME - OFF - LITHIUM WEEKS 
Fig. 2. Correlation between absolute change in maxi- 
mum urinary osmolality and time-off-Li. Least square 
regression line. 
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second analysis) as independent variables (test 
for curvilinearity). 
c. A covariance analysis the sample split in 
two age groups, one over 40, one under 40 
(test for interaction between age and time-on- 
Li) . 
Statistical significance is * = P < 0.05, ** = P 
< 0.01, * * *  = P < 0.001. 
The investigation was approved by the Ethics 
Committee at the Medical Faculty in Gothenburg 
and at the Karolinska Institute, Stockholm. 
Results 
1) Intraindividual comparison of renal function 
tests and weight on and off Li (Table 2). 
Serum creatinine and creatinine clearance did 
not change significantly although both in- 
creased. The number of patients below refer- 
ence range changed accordingly. 
5'Cr-EDTA clearance increased significantly. 
The number of patients below reference range 
for age and sex decreased. With all data on 
Wr-EDTA clerance in patients off Li included, 
seven of 42 patients were below normal. 
Maximal urine osmolality increased 76 mOsm/ 
kg. The number of patients below 800 
mOsm/kg (cut-off level for this study) de- 
creased. 
Urine volume decreased 0.6 1. The number of 
patients with over 3 1 (by definition the level of 
polyuria) also decreased. 
Weight decreased significantly. 
Paired comparison of renal function tests 
between patients on Li and matched controls 
(Table 3). 
Serum creatinine, creatinine clearance and 
s'Cr-EDTA ctearance did not differ signifi- 
cantly between Li-patients and controls, while 
maximum urine osmolality was 136 mOsm 
lower and urine volume 0.9 1 higher, in Li- 
patients than in controls. 
Paired comparison of renal function tests 
between patients off Li and matched controls 
(Table 4). 
Table 7 
Multiple stepwise regression analysis of renal function parame- 
ters on age, sex, diagnosis, and time-on-Li for patients off Li 
S-Cre y = 138 - 7x, - 0 . 4 ~ ~  - 9x3 
(n = 36) R2 = 0.06 
SE = 25.1 
F(3,35) = 0.7 NS 
Cre clearance y = 127 - 24xl** - 0 . 3 ~ ~  + 12x3 
(n = 36) R2 = 0.41 
SE = 22.4 
F(3,35) = 7.6*** 
51Cr-EDTA y = 131 - lox, - 0 . 6 ~ ~  + 3x3 
clearance R2 = 0.31 
(n = 33) SE = 18 
F(3,32) = 4.3* 
U-osmol y = 1,278 - 98xl - 3x, - 43x3 - 
R2 = 0.41 
SE = 141 
F(4.36) = 5.7** 
(n = 37) 2x4** 
v u  y = 1,378 - 41x, - 0 . 6 ~ ~  - 365x3 
(n = 36) R2 = 0.04 
SE = 943 
F(3,35) = 0.49 NS 
R2 = determination coefficient; SE = standard error of the. 
regression; x1 = sex, x2 = age, x3 = diagnosis, x4 = time-on-Li. 
Regression equations are the final ones. 
Abbreviations as in Table 2. 
3) 
Serum creatinine was somewhat higher, and 
maximal urine osmolality 68 mOsm/kg lower 
in Li-patients than in controls. Nineteen (59 To) 
of the Li-patients and 13 (41 To) of the controls 
were below 800 mOsm/kg. 
Creatine clearance, 51Cr-EDTA clearance, and 
urine volume did not differ significantly 
between Li-patients and controls. 
Simple correlations on and off Li (Tables 5 and 
6 ) .  
Average S-Li did not correlate significantly 
with any of the renal parameters. 
Time-on-Li correlated significantly with 
U-osmol and Vu in patients on Li, and with 
U-osmol (Fig. 1) but not with Vu in patients off 
Li. It did not correlate with S-Cre, Cre or *Cr- 
EDTA clearance. In addition, it correlated with 
diff U-osmol (n = 44, r = -0.38*) and ratio 
U-osmol (n = 44, r = -0.34*). 





disease Neuroleptic treatment Renal disease 
UP BP CP US SCH 0 1 0 1 0  1 2 
Diagnosis 
UP 7 5 




r n  $ Renal disease' 
.- 24 2 
1 3 1  n 
; ; i o  
Cardiovasuclar disease** 
2 0  23 2 
1 2 2  
Neuroleptic treatment 
0 1 
1 20 1 1 
2 1 6 2  
0 = None. 
1 = Present (for disease). 
1 = Intermediate between 0 and 2 (for neuroleptics). 
2 = 2 2 years of neuroleptic treatment. 
* Data missing in 2 pairs. 
* *  Data missing in 3 pairs. 
Abbreviations as in Table 1. 
Time-off-Li correlated significantly with ratio 
as well as diff U-osmol (Fig. 2 ) .  
Age correlated significantly with V r - E D T A  
clearance and U-osmol in patients on and off Li 
and in controls. In patients off Li, age corre- 
lated significantly also with Ccre. 
Multiple regression analyses in Li-patients. 
Both time-on-Li and time-off-Li contributed 
significantly and in opposite directions to the 
variance in diff U-osmol, while in the case of 
ratio U-osmol only time-off-Li reached signifi- 
cance as a predictor. 
4) Multiple regression analyses off Li (Table 7). 
Since, in the first multiple regression analysis, 
average S-Li did not contribute significantly to 
the variance in any of the five renal function 
parameters, we repeated the analysis, excluding 
average S-Li. This gave us a larger sample and 
one variable less to  account for. Table 7 shows 
that only for Ccre and U-osmol did any of the 
independent variables contribute significantly 
to the variance. In this model, men had a Ccre 
24 ml/min higher than women, while tirne- 
on-Li predicted a decline in U-osmol of 2 
mOsm/rnonth. Within the model, 13 years of 
Li treatment would, therefore, predict a decline 
in U-osmol of about 300 mOsm. Age too, was a 
negative predictor of U-osmol without reach- 
ing significance and would only contribute 
another 40 mOsml during the same 13 years. 
Multiple regression analysis in matched 
groups. 
Time-on-Li contributed significantly to the 
variance in U-osmol difference between pa- 
tients off Li and their matched controls. 
Additional analysis of U-osmol in patients off 
Li, including residual analysis, multiple regres- 
sion analyses (time-on-Li squared and un- 
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squared), and analysis of covariance did not 
indicate any deviation from the straight line 
model, improvement in linear fit by a cur- 
vilinear model (R2 remained practically un- 
changed), or in this small sample, interaction 
between age and duration. The straight line 
model is therefore appropriate, and the effects 
of age and time-on-Li probably additive. 
Discussion 
Sources of error 
As discussed in a previous paper (3), some of the 
data retrieved from patient charts were not par- 
ticularly reliable. This pertains especially to s-Li, 
while information on doses of Li and neurolep- 
tics seemed more reliable. In patients from hospi- 
tal 2, S-Li could not be used for statistical analy- 
sis while time-on-Li and time-on-neuroleptics 
seemed sufficiently accurate. 
Creatinine clearance is a difficult method to  
use for assessment of glomerular function and 
served poorly in this study. 
Maximal urine osmolality in a real sense is not 
achieved by using the DDAVP-method. It per- 
forms reasonably well, however, for screening 
purposes, although it tends to  underestimate the 
maximal concentration capacity, especially in the 
high osmolar range. 
In both Li-patients and controls - more so 
among the former - there were several individu- 
als with a history of physical disease that could 
influence kidney function. As discussed below, 
this influence probably does not invalidate the 
comparison between Li-patients and controls. 
By excluding neuroleptic treatment and exact 
affective diagnosis as matching criteria, the num- 
ber of matched pairs was increased, but addi- 
tional uncontrolled sources of variance were 
simultaneously introduced. It could be argued 
that diagnosis may affect kidney function. Also, 
kidney disease and heart disease were not 
included among the matching criteria. I tried, 
however, to  take all these factors into account 
when arranging the pairs. Concurrent neuroleptic 
treatment may not affect renal function (4). 
Nevertheless, for neuroleptic treatment each 
patient and subject was assigned a dummy varia- 
ble 2, 1 or 0 where 2 = treated with neuroleptics 
of any kind (except for dixyrazim and ali- 
memazin) and any dosage, for altogether 2 years 
or more during their whole lifetime; only contin- 
uous treatment of a t  least 1 week’s duration was 
included; 0 = not treated with neuroleptics. 1 = 
intermediate between 2 and 0. Consequently, I 
was able to  take this factor too into account, 
when arranging the pairs. 
Table 8 demonstrates that exact diagnosis, 
neuroleptic treatment and somatic disease turned 
out to be rather well matched between the two 
groups. 
In addition, some factors of possible impor- 
tance for renal function were not accounted for 
at all, namely number of hospitalizations, medi- 
cation other than neuroleptics, and duration of 
psychiatric illness. It is reasonable to  believe that 
affectively ill Li-patients in this study are more 
heavily weighted on the former two items than 
are the controls. If anything, that would tend to 
increase the difference in renal function between 
the two groups. 
On the other hand, more controls than Li- 
patients were hospitalized at the time of the 
investigation. If  anything, this should give the 
opposite tendency in the above-mentioned fac- 
tor. 
Thyroid function, also, was not included 
among matching criteria. Among 32 Li-patients 
one had an elevated TSH both on and off Li. 
Among 32 controls one had an elevated TSH. In 
both cases the corresponding “twin” had a nor- 
mal TSH. 
Everything considered, including the known 
but quantitatively minor mismatching between 
the two groups, I conclude that the difference in 
renal function between Li-patients and controls 
could be ascribed to the major differentiating 
variable, namely the Li-treatment. 
Renal function 
Bucht & Wahlin (7) found 8 weeks to  be 
sufficient for maximal restoration of renal func- 
tion. Tubular function in their patients had 
improved significantly after 8 weeks off Li and 
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no further improvement was discernible after 
another 10 months off Li. Our analysis of the 
effect of time-off-Li gave somewhat different 
results. We found a significant correlation 
between time-off-Li and absolute and relative 
change in U-osmol (Table 6, Fig. 2). Vu and 
T r - E D T A  clearance, which also improved on Li 
withdrawal, showed no significant correlation 
with time-off-Li. All but five patients had time- 
off-Li for 12 weeks or more. The correlation 
with U-osmol change may therefore indicate that 
tubular function keeps improving for a long time 
after Li withdrawal, i.e. for more than 12 weeks. 
However, the correlation was weak, and as 
shown in Fig. 2 most of the datapoints piled up 
in the lower range of time-off-Li where they 
deviated considerably from the least square 
regression line. 
Serum creatinine was above normal in 4/45 
patients off Li. In two of them V r - E D T A  clear- 
ance was normal, and in the other two slightly 
below normal. In one control S-Cre was bor- 
derline high, V r - E D T A  clearance normal. 5’Cr- 
EDTA clearance was below normal in 7/42 
patients off Li and borderline low in 1/43 of the 
controls. None of them had a history of car- 
diovascular or renal disease (data were lacking 
for the former in 1, for the latter in I ) .  Thus, 
although as a group the Li-patients did not differ 
from controls there may be individuals who have 
a slightly reduced glomerular function, not nec- 
essarily due to  Li treatment. 
Urine osmolality was below 800 mOsm in 26/45 
(58 Vo) patients off Li, and in 18/47 (38 070) con- 
trols. Three of the Li-patients below 800 had a 
history of cardiovascular or renal disease, or 
both, while in two data were lacking for both 
items. Five of the controls below 800 had a 
history of cardiovascular or renal disease. In one 
additional control data were missing for car- 
diovascular disease. Obviously, the use of 800 
mOsm as a cut-off point for abnormality is not 
helpful for the understanding of tubular func- 
tion. No valid conclusion as to  the effect of Li 
treatment on tubular function could be drawn 
from the number of patients below that level. 
Age is a predictor of U-osmol in patients both on 
and off Li and in controls. Hence, the reference 
range for U-osmol should be age-related, as is 
the reference range for clearance. 
Polyuria was present in 24% of Li-patients on 
Li, in 12% off Li, and in 12% of the controls. 
This attests to  the well-known tendency for Li to  
cause an increase in urinary output which reverts 
to  normal once Li is discontinued. “Normal” (as 
defined by the control group) still means about 
1/10 of patients with polyuria. 
Comparison of renal function 
between Li-patients and controls 
a) This study 
U-osmol and Vu differed between patients on Li 
and controls. When Li was withdrawn, all renal 
function parameters but S-Cre indicated a func- 
tional improvement, which reached statistical sig- 
nificance for X r - E D T A  clearance, U-osmol, 
and Vu, and, resulted in a normalization of the 
latter. Consequently, the difference in renal 
function between Li-patients and controls was 
smaller off than on Li except for S-Cre where the 
difference increased. 
The improvement in U-osmol and Vu is due to  
removal of Li-induced vasopressin inhibition and 
to  restoration of the renal medullary osmotic 
gradient. Decrease in secondary polydipsia may 
also contribute. Improvement in GFR is presum- 
ably secondary to  the normalization of water and 
sodium balance. In only one patient did a consid- 
erable polyuria (6.3 1/24 h) and low U-osmol 
(330 mOsm) persist after 3Ih months off Li, 
indicating the possibility of an irreversible diabe- 
tes insipidus-like syndrome. The finding is not an 
unequivocal proof, however, since W-osmol on 
Li was 550, while Vu was the same as off Li. The 
patient had been on Li for 110 m,onths, age was 
41 and diagnosis schizophrenia. At the time of 
the second examination, she had bateriuria and 
hematuria with no signs or symptoms of upper 
urinary tract infection. Nevertheless, one expla- 
nation for a low U-osmol on the second exam- 
ination could be a urinary tract disorder. Prim- 
ary polydipsia also cannot be ruled out. 
In contrast to  Vu, U-osmol remained and 
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S-Cre emerged significantly different between Li- 
patients off Li and controls. The difference in 
S-Cre was small, however, and only three 
patients had a value above reference age, while 
on Li their S-Cre was within normal. The ele- 
vated level of S-Cre in Li-patients may be inter- 
preted as a sign of decreased GFR, an interpreta- 
tion which, however, contradicts the clearance 
levels. In addition, the change in S-Cre between 
on an off Li goes in a direction contrary to both 
Ccre and Wr-EDTA clearance and to expecta- 
tions. A reduced glomerular function, therefore, 
cannot explain the finding. Weight and height 
off Li were not significantly different between 
patients and controls. Thus, difference in body 
mass cannot explain the difference. Controls 
were examined after their respective Li-patient , 
sometimes a couple of years later. No change in 
laboratory routines took place, however, during 
the course of the complete study (March 1978 
through May 1982). Li-treatment may therefore 
be a causative factor behind the relative increase 
in S-Cre, although the evidence is not con- 
vincing. Laboratory error or even chance occur- 
rence cannot be ruled out. 
b) Other studies 
The results of this study summarized above, con- 
firm some of those published by Bucht & Wahlin 
(7) and Vestergaard & Amdisen (8). Those are 
the only studies, in addition to this one, that 
have used a group of Li-patients off Li for 
comparison with a control group. In a fourth 
study by Albrecht (9), where reference values but 
not controls were used, the patients stayed off Li 
for 10 days, which is too short a time for the 
results to  be comparable to the three other stud- 
ies, where patients were Li-free for 7 weeks to  
more than 1 year. In (7) and (8), the authors 
found that in Li-patients who discontinued Li, 
U-osmol returned towards normal but remained 
lower than in pre-Li patients (8), other psychi- 
atric patients and healthy controls (7). None of 
them found a significant change in GFR or S-Cre 
when Li was withdrawn, nor any difference in 
GFR or S-Cre between Li-patients and psychi- 
atric controls. Bucht & Wahlin found that Li- 
patients on and off Li had a significantly higher 
S-Cre than had normal controls. The explanation 
for an elevated S-Cre relative to  psychiatric con- 
trols in our group of patients, but not in others, 
may be found in methodological differences 
between the studies. In ours, body mass and sex 
distribution were similar between the two groups. 
In the other two studies these factors were not 
accounted for and could possibly have been dis- 
tributed by chance in a way which eliminated a 
difference in S-Cre. 
The difference in U-osmol between Li-patients 
and controls is small and clinically insignificant 
but theoretically important, since it confirms the 
hypothesis that Li-treatment may indeed cause 
permanent damage to the kidneys. However, the 
finding of a significant positive correlation 
between time-off-Li and U-osmol change (Table 
6, Fig. 2) raises some doubt about this con- 
clusion. It may indicate that with a sufficiently 
long time-off-Li the difference between Li- 
patients and controls will disappear. Taking this 
factor into account in the statistical analysis, 
however, time-on-Li still remained a significant 
negative predictor of improvement in tubular 
function. 
Relationship between 
and renal function 
Further evidence in this study 
tionship between Li treatment 
ti me-on-Li 
for a causal rela- 
and permanently 
reduced tubular function is the finding of a statis- 
tically significant correlation between U-osmol off 
Li and time-on-Li, and between U-osmol dif- 
ference (between Li-patients and controls) and 
time-on-Li, age held constant in both cases. The 
various regression analyses indicate the same. In 
the two comparable studies (7, 8), the authors also 
found a significant correlation between time-on-Li 
and U-osmol. One of them (7) found a significant 
correlation between time-on-Li and S-Cre off Li, 
as did Vestergaard (10) in patients on Li. We were 
unable to replicate these latter findings. 
As evidenced by Fig. 1, U-osmol seems to be 
approaching plasma osmolality (285 mOsm/kg 
H20) when time-on-Li reaches values o f  about 17 
years. However, even if the statistical analysis 
gives support to the straight line model and the 
effects of age and time-on-Li seem additive, the 
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interpretation nevertheless becomes untenable 
beyond the range of the data, namely about 13 
years of Li treatment. Whether Li causes an 
irreversible and pronounced nephrogenic diabe- 
tes insipidus in most patients kept on Li for a 
sufficient length of time remains to be investig- 
ated. 
The mechanism behind the irreversible reduc- 
tion of tubular function is not understood, 
although it seems likely that the high Li con- 
centration in the distal tubule is responsible for 
the damage (1  1). .The pathological anatomy of 
the lesion underlying the functional impairment 
has been repeatedly described (1, 2, 12-15). 
Concerning glomerular function, results are 
even more benign than for tubular function. The 
evidence for an irreversible effect of non-toxic 
Li-treatment is weak and none was added by this 
study, thereby eroding my own conclusion from 
a previous paper (4) that Li may damage 
glomerular function permanently. 
Conclusions 
The answers to the initial questions can now be 
given as follows: 
Li in non-toxic doses for up to 13 years caused 
reversible and irreversible disturbances of renal 
function in this group of Li-patients. The find- 
ings can probably be generalized to other popu- 
lations of Li-patients fulfilling the same inclu- 
sion criteria. 
The reversible disturbance affects both tubu- 
lar and glomerular function. 
The irreversible disturbance affects only tubu- 
lar function. It is, however, clinically insig- 
nificant up to this point in time. 
Time-on-Li is a risk factor for tubular func- 
tion. 
It also follows that the evaluation of true 
renal function when Li-patients are on Li is 
severely handicapped by the confounding 
reversible effect of Li on both glomerular and 
tubular function. 
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